MedPath

Weight Loss in Pre-diabetic, Obese Women

Phase 2
Completed
Conditions
Obesity
Interventions
Dietary Supplement: Low calorie diet
Dietary Supplement: Olestra
Registration Number
NCT00686816
Lead Sponsor
Procter and Gamble
Brief Summary

This is a six (6) month, single center, randomized, double-blind, parallel, controlled-feeding weight-loss study comparing two dietary groups (triglyceride and olestra) in pre-diabetic obese women.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • Premenopausal
  • BMI 30-45 kg/meter squared
  • waist circumference greater than 88 cm
  • blood glucose level 5.8-6.9 mmol/l
Exclusion Criteria
  • Pre-diabetic
  • pregnant
  • nursing
  • food preferences not compatible with the study diet
  • allergies or food sensitivities with any of the study diet

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Low calorie diet-
2Olestra-
Primary Outcome Measures
NameTimeMethod
weight loss3 months
Secondary Outcome Measures
NameTimeMethod
Weight maintained6 months

Trial Locations

Locations (1)

Vasily Isakov, MD

🇷🇺

Moscow, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath